The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
CMS’ Innovation Center is offering the third and final session of its ACO Accelerated Development Learning Sessions. ACO Accelerated Development Learning Sessions are designed to provide executive ...
As the digital landscape continues to grow, businesses must pursue their customers in every possible location, which means scalable, high-performance solutions with omnichannel accessibility needs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results